NCT05140902 2025-02-14
Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
University of Alabama at Birmingham
Phase NA Completed
Clinical Trials
17 trialsNCT03557372 2023-10-26
Mathematical Model-Adapted Radiation In Glioblastoma
Dana-Farber Cancer Institute
Phase NA Completed
NCT03538587 2023-08-01
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
National Institutes of Health Clinical Center (CC)
Phase NA Completed
NCT01925573 2022-02-03
Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
University of Maryland, Baltimore
Phase NA Terminated
NCT02076152 2021-07-30
FMISO PET Study of Glioblastoma
Massachusetts General Hospital
Phase NA Completed
NCT01754350 2021-06-02
ERGO2
Johann Wolfgang Goethe University Hospital
Phase NA Completed
NCT01987830 2020-09-04
Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
Massachusetts General Hospital
Phase NA Completed
NCT00756106 2020-05-13
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
Massachusetts General Hospital
Phase NA Terminated
NCT02431572 2020-04-28
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
Massachusetts General Hospital
Phase NA Completed
NCT01540513 2019-12-02
PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
University of Wisconsin, Madison
Phase NA Completed
NCT02374255 2019-10-01
Improving Goals of Care Discussion in Advanced Cancer Patients
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT01478854 2019-06-13
Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT02410577 2019-03-19
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT02966509 2018-10-31
EPAC
Stanford University
Phase NA Completed
NCT00631137 2018-08-27
Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Terminated
NCT01342757 2018-01-29
Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
National Cancer Institute (NCI)
Phase NA Completed
NCT02039778 2017-06-05
STRONG
Beth Israel Medical Center
Phase NA Terminated